胸壁损伤学会推荐:手术稳定治疗创伤后肋骨骨折不愈合以减轻疼痛、减少阿片类药物使用并改善患者报告结局
肋骨骨折常见,多数可达到骨性愈合,但部分患者发生不愈合,处理具有挑战性且存在差异。胸壁损伤学会(CWIS)出版委员会通过检索 PubMed、Embase 和 Cochrane 数据库,采用迭代共识流程制定推荐。未发现比较手术稳定治疗不愈合肋骨骨折(SSNURF)与替代疗法的研究,总体证据质量评为低,所有研究均存在偏倚风险。尽管有这些局限,较低质量证据提示 SSNURF 可能对减轻有症状肋骨不愈合患者的疼痛、减少阿片类药物使用和改善患者报告结局有益,但需权衡有症状的硬件失效和感染风险。
要点
- 未发现比较 SSNURF 与替代疗法的研究,总体证据质量评为低,所有研究均存在偏倚风险。
- 较低质量证据提示 SSNURF 可能对减轻有症状肋骨不愈合患者的疼痛有益。
- 较低质量证据提示 SSNURF 可能对减少有症状肋骨不愈合患者的阿片类药物使用有益。
- 较低质量证据提示 SSNURF 可能对改善有症状肋骨不愈合患者的患者报告结局有益。
- SSNURF 的获益需与有症状的硬件失效和感染风险相权衡。
适用人群与场景
- 创伤后肋骨骨折不愈合的患者
- 有症状的肋骨不愈合患者
研究设计与关键结果
- 未发现比较 SSNURF 与替代疗法的研究,总体证据质量评为低,所有研究均存在偏倚风险。
- 较低质量证据提示 SSNURF 可能对减轻有症状肋骨不愈合患者的疼痛有益。
- 较低质量证据提示 SSNURF 可能对减少有症状肋骨不愈合患者的阿片类药物使用有益。
- 较低质量证据提示 SSNURF 可能对改善有症状肋骨不愈合患者的患者报告结局有益。
- SSNURF 的获益需与有症状的硬件失效和感染风险相权衡。
证据类型、等级与局限
- 证据类型:指南;证据等级:治疗/管理,Level IV。
- 局限:未发现比较 SSNURF 与替代疗法的研究;总体证据质量评为低;所有研究均存在偏倚风险。
对床旁实践的改变
- 对于有症状的创伤后肋骨骨折不愈合患者,SSNURF 可能对减轻疼痛、减少阿片类药物使用和改善患者报告结局有益,但需权衡有症状的硬件失效和感染风险。
指南或共识出处
- Chest Wall Injury Society recommendation for surgical stabilization of nonunited rib fractures to decrease pain, reduce opiate use, and improve patient reported outcomes in patients with rib fracture nonunion after trauma(胸壁损伤学会)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rib fractures are common injuries which can be associated with acute pain and chronic disability. While most rib fractures ultimately go on to achieve bony union, a subset of patients may go on to develop non-union. Management of these nonunited rib fractures can be challenging and variability in management exists.
METHODS: The Chest Wall Injury Society's Publication Committee convened to develop recommendations for use of surgical stabilization of nonunited rib fractures (SSNURF) to treat traumatic rib fracture nonunions. PubMed, Embase, and the Cochrane database were searched for pertinent studies. Using a process of iterative consensus, all committee members voted to accept or reject the recommendation.
RESULTS: No identified studies compared SSNURF to alternative therapy and the overall quality of the body of evidence was rated as low. Risk of bias was identified in all studies. Despite these limitations, there is lower-quality evidence suggesting that SSNURF may be beneficial for decreasing pain, reducing opiate use, and improving patient reported outcomes among patients with symptomatic rib nonunion. However, these benefits should be balanced against risk of symptomatic hardware failure and infection.
CONCLUSION: This guideline document summarizes the current CWIS recommendations regarding use of SSNURF for management of rib nonunion.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Forrester JD, Bauman ZM, Cole PA, et al. Chest Wall Injury Society recommendation for surgical stabilization of nonunited rib fractures to decrease pain, reduce opiate use, and improve patient reported outcomes in patients with rib fracture nonunion after trauma. J Trauma Acute Care Surg. 2023. PMID: 37728432. doi:10.1097/TA.0000000000004083
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。